WARSAW, Ind., March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA ...

Zimmer Biomet appoints Kristen Cardillo as SVP and Chief Communications Officer to lead global strategy and stakeholder engagement.

Zimmer Biomet Holdings, Inc. has a 52 week low of $97.69 and a 52 week high of $133.90. The company has a current ratio of 1.91, a quick ratio of 0.70 and a debt-to-equity ratio of 0.43.

WARSAW, Ind., Feb. 25, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced upcoming changes to the Company's Board of ...

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, has entered into a strategic distribution agreement with Promamec, a leading provider of medical devices in ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has announced the issuance of a series of new notes totaling $1.75 billion on Wednesday. The medical device company, currently trading near its 52-week low ...

WARSAW, Ind. - Zimmer Biomet Holdings, Inc. (NYSE:ZBH), a notable player in the medical technology industry with a market capitalization of $20.89 billion and impressive gross profit margins of 71 ...

WARSAW, Ind., Feb. 26, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the ...

Zimmer Biomet Holdings, Inc. has a 1-year low of $97.69 and a 1-year high of $133.90. Zimmer Biomet ( NYSE:ZBH – Get Free Report ) last posted its earnings results on Thursday, February 6th.

Zimmer Biomet Holdings, Inc. (ZBH) is a global medical technology company specializing in musculoskeletal healthcare solutions with a market cap of $19.7 billion. Headquartered in Warsaw ...